Zehra Jaffery is a Cardiology physician affiliated with Southern Methodist University. OpenAlex indexes 40 publications with 395 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
880 W Central Rd Ste 7100
Arlington Heights, IL 600052379
Telephone
847-618-2500Provider last certified this registry record 29 Apr 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202512 payments
- Medtronic, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year202414 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.9%Beta blocker22.4%Metoprolol Tartrate53%Carvedilol23%Metoprolol Succinate17%Atenolol5%Labetalol Hcl2%Part D<11 patientsStatin22.2%Atorvastatin Calcium66%Rosuvastatin Calcium25%Pravastatin Sodium5%Simvastatin4%Part D<11 patients+ 11 more classes in this area
Blood & clotting
16.1%Factor Xa inhibitor13.1%Eliquis87%Xarelto14%Part D≥92 patientsP2Y12 inhibitor1.7%Clopidogrel100%Part D≥19 patients+ 1 more class in this area
Metabolism & gastrointestinal
1%Potassium supplement0.6%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor0.5%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Breaking ground: insights from a WHO-approved surgical mission amid Sudan's healthcare collapse
Frontiers in Public Health
2026 - F-83 | Elevated C- Reactive Protein Identifies a High-Risk Inflammatory Phenotype in Immune Checkpoint Inhibitor-Associated Myocarditis
Journal of the Society for Cardiovascular Angiography & Interventions
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”